Search results
Are pet food recalls rising?
Newsweek· 48 minutes agoPet food recalls have increased in recent years, according to U.S. Food and Drug Administration (FDA) records reviewed by Newsweek. The number of pet food-related ...
FDA lifts hold on Larimar's Friedreich's Ataxia drug study By Investing.com
Investing.com· 7 hours agoS. Food and Drug Administration (FDA) has lifted the partial clinical hold on its nomlabofusp...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 2 hours agoAdministered intravitreally into the eye as a 2mg injectable solution, Yesafili and Opuviz follow...
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
WFRV 5 Green Bay· 4 hours agoKS) and Novel Pharma have announced that the U.S. FDA has cleared the investigational new drug (IND) application for their jointly developed MPSIIIA (Sanfilippo ...
Roche's Inavolisib Breast Cancer Treatment Gets FDA Breakthrough Therapy Designation
Market Watch· 5 hours agoBy Pierre Bertrand Roche said that the U.S. Food and Drug Administration has designated its Inavolisib breast cancer treatment as a breakthrough therapy. A...
LDTs: FDA Rolls Out a Phased Implementation for New Regulatory Requirements
The National Law Review· 21 hours agoOn May 6, 2024, the U.S. Food and Drug Administration (FDA) issued its final rule significantly...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 16 hours agoIn comments to Barron’s on Monday, vaccine manufacturers seemed unfazed by the delay. A Moderna...
FDA gives Neuralink another shot at brain chip – report
The Register· 13 hours agoThe Elon Musk startup also hopes to perform ten tryouts by the end of the year. The FDA's go-ahead...
DentalMonitoring gains De Novo approval for orthodontic solution
Medical Device Network via Yahoo Finance· 2 hours agoThe authorisation allows orthodontists to utilise the DentalMonitoring...advanced image processing...
FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer
MedPage Today· 1 day agoThe FDA has withdrawn the approval of infigratinib (Truseltiq) as a second-line treatment for...
